COVID ?
, COVID, , , .
, COVID, , , - .
, « », , , - .
, .
, , , , .
, , COVID, , .
, , COVID, .
COVID , , .
348 , COVID 2022 2023 , . 16 ; 39 . 65% .
COVID — , .
, , , , .
« – , », – , , - -.
, COVID .
« , », — . « : , , , ?»
COVID, , .
, COVID, , , , .
« , - COVID-19, , , , , », — .
, , .
2022 , JAMA Internal Medicine, . , .
(FDA) , , .
, - , « [ ] ».
, - , : - , .
. -, , .
COVID ,
, , COVID, .
« », — .
, (CDC) 48 -, .
, ( , , ), , .
« , , , », , — .
, -. , COVID , , , , , . .
COVID, - , - .
.
, , .
:
- Frediani JK, Parsons R, McLendon KB, et al. The new normal: delayed peak SARS-CoV-2 viral loads relative to symptom onset and implications for COVID-19 testing programs. Clin Infect Dis. Published online September 28, 2023. doi:10.1093/cid/ciad582
- National Institutes of Health (NIH). COVID-19 Treatments.
- Chu VT, Schwartz NG, Donnelly MAP, et al. Comparison of home antigen testing with RT-PCR and viral culture during the course of SARS-CoV-2 infection. JAMA Intern Med. 2022;182(7):701-709. doi:10.1001/jamainternmed.2022.1827
- Food and Drug Administration. At-home COVID-19 antigen tests—take steps to reduce your risk of false negative results: FDA safety communication.
- Centers for Disease Control and Prevention. COVID-19 testing: what you need to know.





